...BRCA2 and a quarter were BRCA1 carriers. The rest were positive for both genes. Hormone-replacement therapy was initiate...
...BRCA2 have been well investigated. These genes are widely accepted as the predisposing factors that trigger malignant tr...
...BRCA2-interacting protein BCCIP as the platform, we found that a conditional BCCIP knockdown and concomitant p53 deletio...
...BRCA2, along with rare intermediate-risk genes and common low-penetrance alleles identified, altogether explain no more ...
...BRCA2 mutation causing PD with normal bone marrow analysis. In addition, we have identified a novel locus for Seckel syn...
...BRCA2 and ERCC1). Our findings suggest that the cisplatin-DNA adduct level is the most important determinant of cisplati...
...BRCA2 breast tumors showed specific differences even across the two sub-types and revealed novel genes involved therein ...
...BRCA2 and CDKN1A interacting protein) is essential for maintaining the transactivation activity of wild type p53. We ana...
...BRCA2 and MUS81. In line with these results, we found that FANCD2-containing APBs form in an ATR-dependent manner in HPV...
...BRCA2. It has also been suggested that BRCA1 mutation is involved given the fact that BRCA1 mutation carriers are at inc...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
